Press Releases
The Value of Reducing Your Drug Development Timeline
SAMSUNG BIOLOGICS
SPEED MATTERS
The Value of Reducing Your Drug Development Timeline
Getting a biologic drug from development to market can be challenging
- It takes at least 10-15 years form discovery to market
- Average of $2.6 billion to develop a new drug
The drug lifecycle of discovery, development, and approval process is time-intensive
1. DISCOVERY/PRECLNICAL TESTING 2. DEVELOPMENT 3.APPROVAL
Average of 10-15 YEARS from Discovery to Approval
- Discovery & Proof of Concept (PoC)
- 6.5 YEARS
- Assess safety, biological activity, and formulations
- Phase 1
- 1.5 YEARS
- Determine safety and dosage
- Phase 2
- 2 YEARS
- Evaluate effectvencess, look for side effects
- Phase 3
- 3.5 YEARS
- Confirm effectvencess, monitor adverse reactions from long-term use
- FDA
- 1.5 YEARS
- Review and approval process
- Additional post-marketing testing repuired by regulatory agencies
Drug approval is a long journey with countless hurdles along thw way
- MORE THAN 13,583 CANDIDATES are ay the pre-IND stage for biologics
- 13,583
- Pre-IND
- 31.8%
- LESS THAN 1/3 CABDIDATES make it to clinical trials
- 4,319
- clinical trials
- 9.6%
- ONLY 3% OF THESE CABDIDATES will successfully make it to market
- 415
- Approved
Unexpected delays during the journey causes significant cash burn and loss of opportunities
85% of clinical trials are delays
43% of companies report lacking the necessary agility and redundancy to respond to supply chain disruptions due to COVID-19
Recent research found that $600,000 to $8million is not every day due to delay in development and commercialization
According to a recent study, First-to-market entrants achieve the greatest matket share
- 1st pioneer
- 40%
- 2nd pioneer
- 33%
- 3rd
- 19%
- 4th
- 13%
- 5th
- 8%
- 6th
- 2%
Average market share (measured by sales) based on anallusis of 492 drug launches in 131 classes over a 27-year period
TIME TO MARKET MATTERS
Samsumg Biologics accelerates your journey from development to commercialization
- Speed
- ACCELERATED TIMELINE
- From DNA to IND as fast as 9 months using our Faster & Better established processes
- Infrastructure
- END-TO-END MANUFACTURING CAPACITY
- Multiscale capacity providing end-to-end service offerings with flexibility with utmost speed and cost-effectiveness
- Expertise
- ONE DEDICATED TEAM
- A dedicated team to quickly drive your Projects to completion from early development through clinical and commercial manufacturing
Fast-track your pipeline with us to augment your capacity and expertise, refind your processes, and ultimately shorten your time to market
Related contents
Samsung BIO Insight The Benefit of Speed, Scale & Quality | Explore Samsung Biologics' CMO Strengths
Samsung BIO Insight Advance Your Molecule to Success with a True End-to-End Partner
Whitepapers Redefining Speed In Drug Development : Samsung Biologics' S-Cellerate™ Platform
SAMSUNG BIOLOGICS
SPEED MATTERS
The Value of Reducing Your Drug Development Timeline
Getting a biologic drug from development to market can be challenging
- It takes at least 10-15 years form discovery to market
- Average of $2.6 billion to develop a new drug
The drug lifecycle of discovery, development, and approval process is time-intensive
1. DISCOVERY/PRECLNICAL TESTING 2. DEVELOPMENT 3.APPROVAL
Average of 10-15 YEARS from Discovery to Approval
- Discovery & Proof of Concept (PoC)
- 6.5 YEARS
- Assess safety, biological activity, and formulations
- Phase 1
- 1.5 YEARS
- Determine safety and dosage
- Phase 2
- 2 YEARS
- Evaluate effectvencess, look for side effects
- Phase 3
- 3.5 YEARS
- Confirm effectvencess, monitor adverse reactions from long-term use
- FDA
- 1.5 YEARS
- Review and approval process
- Additional post-marketing testing repuired by regulatory agencies
Drug approval is a long journey with countless hurdles along thw way
- MORE THAN 13,583 CANDIDATES are ay the pre-IND stage for biologics
- 13,583
- Pre-IND
- 31.8%
- LESS THAN 1/3 CABDIDATES make it to clinical trials
- 4,319
- clinical trials
- 9.6%
- ONLY 3% OF THESE CABDIDATES will successfully make it to market
- 415
- Approved
Unexpected delays during the journey causes significant cash burn and loss of opportunities
85% of clinical trials are delays
43% of companies report lacking the necessary agility and redundancy to respond to supply chain disruptions due to COVID-19
Recent research found that $600,000 to $8million is not every day due to delay in development and commercialization
According to a recent study, First-to-market entrants achieve the greatest matket share
- 1st pioneer
- 40%
- 2nd pioneer
- 33%
- 3rd
- 19%
- 4th
- 13%
- 5th
- 8%
- 6th
- 2%
Average market share (measured by sales) based on anallusis of 492 drug launches in 131 classes over a 27-year period
TIME TO MARKET MATTERS
Samsumg Biologics accelerates your journey from development to commercialization
- Speed
- ACCELERATED TIMELINE
- From DNA to IND as fast as 9 months using our Faster & Better established processes
- Infrastructure
- END-TO-END MANUFACTURING CAPACITY
- Multiscale capacity providing end-to-end service offerings with flexibility with utmost speed and cost-effectiveness
- Expertise
- ONE DEDICATED TEAM
- A dedicated team to quickly drive your Projects to completion from early development through clinical and commercial manufacturing
Fast-track your pipeline with us to augment your capacity and expertise, refind your processes, and ultimately shorten your time to market
Related contents
Samsung BIO Insight The Benefit of Speed, Scale & Quality | Explore Samsung Biologics' CMO Strengths
Samsung BIO Insight Advance Your Molecule to Success with a True End-to-End Partner
Whitepapers Redefining Speed In Drug Development : Samsung Biologics' S-Cellerate™ Platform